These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 697353)

  • 1. In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli.
    DiPersio JR; Krafczyk TL
    Antimicrob Agents Chemother; 1978 Aug; 14(2):274-6. PubMed ID: 697353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin.
    Crowe CC; Sanders WE
    Antimicrob Agents Chemother; 1974 Mar; 5(3):272-5. PubMed ID: 4840436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.
    Santoro J; Kaye D; Levison ME
    Antimicrob Agents Chemother; 1976 Jul; 10(1):188-90. PubMed ID: 984752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The susceptibility of anaerobic bacteria to rosamicin, erythromycin and clindamycin and factors affecting the activity of rosamicin.
    Kwok YY; Sutter VL; Oberhammer I; Finegold SM
    J Antimicrob Chemother; 1979 Jan; 5(1):61-6. PubMed ID: 33142
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activity of rosamicin, josamycin, erythromycin, and clindamycin against beta-lactamase-nagative and beta-lactamase-positive strains of Neisseria gonorrhoeae.
    Biddle JW; Thornsberry C
    Antimicrob Agents Chemother; 1979 Feb; 15(2):243-5. PubMed ID: 106776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosamicin: in vitro activity against anaerobes and comparison with erythromycin.
    Sutter VL; Finegold SM
    Antimicrob Agents Chemother; 1976 Feb; 9(2):350-1. PubMed ID: 1267432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin.
    Shadomy S; Tipple M; Paxton L
    Antimicrob Agents Chemother; 1976 Oct; 10(4):773-5. PubMed ID: 984811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro comparison of rosamicin and erythromycin against urinary tract pathogens.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1979 Jul; 16(1):69-73. PubMed ID: 112920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the in vitro activity of rosamicin, erythromycin, clindamycin, metroidazole and ornidazole against Haemophilus ducreyi, including beta-lactamase producing strains.
    Feltham S; Ronald AR; Albritton WL
    J Antimicrob Chemother; 1979 Nov; 5(6):731-4. PubMed ID: 317079
    [No Abstract]   [Full Text] [Related]  

  • 10. Rosamicin: in vitro activity comparison with erythromycin and other antibiotics against clinical isolates from the genito-urinary tract and Neisseria meningitidis.
    Fuchs PC; Thornsberry C; Barry AL; Jones RN; Gavan TL; Gerlach EH; Sommers HM
    J Antibiot (Tokyo); 1979 Sep; 32(9):920-7. PubMed ID: 41833
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the in vitro activity of rosamicin, erythromycin, spiramycin, penicillin and tetracycline against N. gonorrhoeae, including beta-lactamase producing isolates.
    Dillon JR; Duck PD; Eidus L
    J Antimicrob Chemother; 1978 Sep; 4(5):477-80. PubMed ID: 99424
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug sensitivity of glucose-nonfermenting bacteria other than Pseudomonas aeruginosa (author's transl)].
    Sato K; Matsumiya H; Saito A
    Jpn J Antibiot; 1979 Dec; 32(12):1378-84. PubMed ID: 119072
    [No Abstract]   [Full Text] [Related]  

  • 13. Rosamicin, a macrolide with in vitro activity against Ureaplasma urealyticum.
    Hill AC; Sutton G
    J Antibiot (Tokyo); 1979 Sep; 32(9):915-9. PubMed ID: 511782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of common clinical anaerobic and aerobic isolates against josamycin.
    Reese RE; Betts RF; Goedde LW; Douglas RG
    Antimicrob Agents Chemother; 1976 Aug; 10(2):253-7. PubMed ID: 984766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.
    Barlam T; Neu HC
    Antimicrob Agents Chemother; 1984 Apr; 25(4):529-31. PubMed ID: 6732223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin.
    Rolston KV; LeBlanc B; Ho DH
    J Antimicrob Chemother; 1986 Feb; 17(2):161-3. PubMed ID: 3700283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.
    Westerman EL; Williams TW; Moreland N
    Antimicrob Agents Chemother; 1976 Jun; 9(6):988-93. PubMed ID: 7189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity and clinical efficacy of clindamycin in the treatment of infections due to anaerobic bacteria.
    Levison ME; Santoro J; Bran JL; Ries K; Rubin W
    J Infect Dis; 1977 Mar; 135 Suppl():S49-53. PubMed ID: 850091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of skin and throat strains of group A streptococci to rosamicin and erythromycin.
    Saroglou G; Bisno AL
    Antimicrob Agents Chemother; 1978 Apr; 13(4):701-2. PubMed ID: 27141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro comparison of roxithromycin and erythromycin against 900 anaerobic bacterial strains.
    Dubreuil L
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():13-9. PubMed ID: 3429381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.